Copyright Reports & Markets. All rights reserved.

(Post-pandemic Era)-Global Lateral Flow Immunoassays Market Segment Research Report 2022

Buy now

Table of Contents

    Global Lateral Flow Immunoassays Market Segment Research Report 2022

      1. Research Scope

        2. Market Overview

        • 2.1 Product Introduction, Application, Picture
        • 2.2 Global Lateral Flow Immunoassays Market by Value
          • 2.2.1 Global Lateral Flow Immunoassays Revenue by Type
          • 2.2.2 Global Lateral Flow Immunoassays Market by Value (%)
        • 2.3 Global Lateral Flow Immunoassays Market by Production
          • 2.3.1 Global Lateral Flow Immunoassays Production by Type
          • 2.3.2 Global Lateral Flow Immunoassays Market by Production (%)

        3. The Major Driver of Lateral Flow Immunoassays Industry

        • 3.1 Historical & Forecast Global Lateral Flow Immunoassays Demand
        • 3.2 Largest Application for Lateral Flow Immunoassays (2018-2028)
        • 3.3 The Major Downstream Company in China Market 2022

        4. Global and Regional Lateral Flow Immunoassays Market

        • 4.1 Regional Market Size in Terms of Production & Demand (2022)
        • 4.2 Regional Market Share in Terms of Revenue (2018-2022)
        • 4.3 Concentration Ratio (CR5& CR10) of Lateral Flow Immunoassays Market
        • 4.4 Mergers & Acquisitions, Expansion Plans

        5. US Lateral Flow Immunoassays Production, Demand (2018-2028)

        • 5.1 Current and Estimated Production Breakdown by Type
        • 5.2 Current and Estimated Demand Breakdown by Type
        • 5.3 Current and Estimated Demand Breakdown by Application
        • 5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        6. Europe Lateral Flow Immunoassays Production, Demand (2018-2028)

        • 6.1 Current and Estimated Production Breakdown by Type
        • 6.2 Current and Estimated Demand Breakdown by Type
        • 6.3 Current and Estimated Demand Breakdown by Application
        • 6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        7. China Lateral Flow Immunoassays Production, Demand (2018-2028)

        • 7.1 Current and Estimated Production Breakdown by Type
        • 7.2 Current and Estimated Demand Breakdown by Type
        • 7.3 Current and Estimated Demand Breakdown by Application
        • 7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        8. Japan Lateral Flow Immunoassays Production, Demand (2018-2028)

        • 8.1 Current and Estimated Production Breakdown by Type
        • 8.2 Current and Estimated Demand Breakdown by Type
        • 8.3 Current and Estimated Demand Breakdown by Application
        • 8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        9. India Lateral Flow Immunoassays Production, Demand (2018-2028)

        • 9.1 Current and Estimated Production Breakdown by Type
        • 9.2 Current and Estimated Demand Breakdown by Type
        • 9.3 Current and Estimated Demand Breakdown by Application
        • 9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        10. Korea Lateral Flow Immunoassays Production, Demand (2018-2028)

        • 10.1 Current and Estimated Production Breakdown by Type
        • 10.2 Current and Estimated Demand Breakdown by Type
        • 10.3 Current and Estimated Demand Breakdown by Application
        • 10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        11. Southeast Asia Lateral Flow Immunoassays Production, Demand (2018-2028)

        • 11.1 Current and Estimated Production Breakdown by Type
        • 11.2 Current and Estimated Demand Breakdown by Type
        • 11.3 Current and Estimated Demand Breakdown by Application
        • 11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        12. Global Lateral Flow Immunoassays Average Price Trend

        • 12.1 Market Price for Each Type of Lateral Flow Immunoassays in US (2018-2022)
        • 12.2 Market Price for Each Type of Lateral Flow Immunoassays in Europe (2018-2022)
        • 12.3 Market Price for Each Type of Lateral Flow Immunoassays in China (2018-2022)
        • 12.4 Market Price for Each Type of Lateral Flow Immunoassays in Japan (2018-2022)
        • 12.5 Market Price for Each Type of Lateral Flow Immunoassays in India (2018-2022)
        • 12.6 Market Price for Each Type of Lateral Flow Immunoassays in Korea (2018-2022)
        • 12.7 Market Price for Each Type of Lateral Flow Immunoassays in Southeast Asia (2018-2022)

        13. Industrial Chain (Impact of COVID-19)

        • 13.1 Lateral Flow Immunoassays Industrial Chain Analysis
        • 13.2 Downstream
        • 13.3 Impact of COVID-19
        • 13.4 Post-pandemic Era
        • 13.5 Technology Trends of Lateral Flow Immunoassays

        14. Lateral Flow Immunoassays Competitive Landscape

        • 14.1 Abbott Laboratories
          • 14.1.1 Abbott Laboratories Company Profiles
          • 14.1.2 Abbott Laboratories Product Introduction
          • 14.1.3 Abbott Laboratories Lateral Flow Immunoassays Sales, Revenue (2018-2022)
          • 14.1.4 Strategic initiatives
        • 14.2 F. Hoffmann-La Roche AG
          • 14.2.1 F. Hoffmann-La Roche AG Company Profiles
          • 14.2.2 F. Hoffmann-La Roche AG Product Introduction
          • 14.2.3 F. Hoffmann-La Roche AG Lateral Flow Immunoassays Sales, Revenue (2018-2022)
          • 14.2.4 Strategic initiatives
        • 14.3 Danaher Corporation
          • 14.3.1 Danaher Corporation Company Profiles
          • 14.3.2 Danaher Corporation Product Introduction
          • 14.3.3 Danaher Corporation Lateral Flow Immunoassays Sales, Revenue (2018-2022)
          • 14.3.4 Strategic initiatives
        • 14.4 Siemens AG
          • 14.4.1 Siemens AG Company Profiles
          • 14.4.2 Siemens AG Product Introduction
          • 14.4.3 Siemens AG Lateral Flow Immunoassays Sales, Revenue (2018-2022)
          • 14.4.4 Strategic initiatives
        • 14.5 Becton, Dickinson and Company
          • 14.5.1 Becton, Dickinson and Company Company Profiles
          • 14.5.2 Becton, Dickinson and Company Product Introduction
          • 14.5.3 Becton, Dickinson and Company Lateral Flow Immunoassays Sales, Revenue (2018-2022)
          • 14.5.4 Strategic initiatives
        • 14.6 bioMérieux SA
          • 14.6.1 bioMérieux SA Company Profiles
          • 14.6.2 bioMérieux SA Product Introduction
          • 14.6.3 bioMérieux SA Lateral Flow Immunoassays Sales, Revenue (2018-2022)
          • 14.6.4 Strategic initiatives
        • 14.7 Bio-Rad Laboratories, Inc.
          • 14.7.1 Bio-Rad Laboratories, Inc. Company Profiles
          • 14.7.2 Bio-Rad Laboratories, Inc. Product Introduction
          • 14.7.3 Bio-Rad Laboratories, Inc. Lateral Flow Immunoassays Sales, Revenue (2018-2022)
          • 14.7.4 Strategic initiatives
        • 14.8 Thermo Fisher Scientific Inc.
          • 14.8.1 Thermo Fisher Scientific Inc. Company Profiles
          • 14.8.2 Thermo Fisher Scientific Inc. Product Introduction
          • 14.8.3 Thermo Fisher Scientific Inc. Lateral Flow Immunoassays Sales, Revenue (2018-2022)
          • 14.8.4 Strategic initiatives
        • 14.9 QIAGEN
          • 14.9.1 QIAGEN Company Profiles
          • 14.9.2 QIAGEN Product Introduction
          • 14.9.3 QIAGEN Lateral Flow Immunoassays Sales, Revenue (2018-2022)
          • 14.9.4 Strategic initiatives
        • 14.10 PerkinElmer Inc.
          • 14.10.1 PerkinElmer Inc. Company Profiles
          • 14.10.2 PerkinElmer Inc. Product Introduction
          • 14.10.3 PerkinElmer Inc. Lateral Flow Immunoassays Sales, Revenue (2018-2022)
          • 14.10.4 Strategic initiatives
        • 14.11 Hologic Inc.
        • 14.12 Quidel Corporation
        • 14.13 Merck KGaA

        15. Conclusion

          16. Methodology and Data Source

          Summary

          The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

          2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

          According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

          Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch)released the 《(Post-pandemic Era)-Global Lateral Flow Immunoassays Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Lateral Flow Immunoassays industry at home and abroad, estimate the overall market scale of the Lateral Flow Immunoassays industry and the market share of major countries, Lateral Flow Immunoassays industry, and study and judge the downstream market demand of Lateral Flow Immunoassays through systematic research, Analyze the competition pattern of Lateral Flow Immunoassays, so as to help solve the pain points of various stakeholders in Lateral Flow Immunoassays industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

          Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Lateral Flow Immunoassays Market by XYZResearch Include
          USA
          Europe
          China
          Japan
          India
          Korea
          Southeast Asia
          Competitive Analysis; Who are the Major Players in Lateral Flow Immunoassays Market?
          Abbott Laboratories
          F. Hoffmann-La Roche AG
          Danaher Corporation
          Siemens AG
          Becton, Dickinson and Company
          bioMérieux SA
          Bio-Rad Laboratories, Inc.
          Thermo Fisher Scientific Inc.
          QIAGEN
          PerkinElmer Inc.
          Hologic Inc.
          Quidel Corporation
          Merck KGaA
          Major Type of Lateral Flow Immunoassays Covered in XYZResearch report:
          Kits & Reagents
          Lateral Flow Readers
          Digital/Mobile Readers
          Benchtop Readers
          Application Segments Covered in XYZResearch Market
          Hospitals and Clinics
          Diagnostic Laboratories
          Home Care
          Pharmaceutical and Biotechnology Companies
          Others

          For any other requirements, please feel free to contact us and we will provide you customized report.

          Buy now